HCV Populations
Interferon-Free Hepatitis C Treatment Safe and Effective for People Who Inject Drugs
- Details
- Category: People Who Inject Drugs
- Published on Saturday, 03 September 2016 00:00
- Written by Liz Highleyman
Chronic hepatitis C patients on opioid substitution therapy, including those who continue to use illicit drugs, maintained good adherence and had high sustained response rates when treated with sofosbuvir/ledipasvir (Harvoni) or sofosbuvir/velpatasvir (Epclusa), according to a pair of ad-hoc analyses published in the August online edition of Clinical Infectious Diseases.
EASL 2016: HCV Therapy Improves Quality of Life for People Who Inject Drugs, Reinfection Risk Remains
- Details
- Category: People Who Inject Drugs
- Published on Wednesday, 27 April 2016 00:00
- Written by Liz Highleyman
People on opiate substitution therapy can be successfully treated with grazoprevir/elbasvir (Zepatier), leading to improvements in some aspects of quality of life, according to findings from the C-EDGE CO-STAR study presented at the European Association for the Study of the Liver's International Liver Congress (EASL 2016) this month in Barcelona. However, the same study saw several cases of hepatitis C virus (HCV) reinfection after a cure, suggesting a greater emphasis on prevention may be warranted.
INHSU 2015: HCV Treatment Works Well for People Who Inject Drugs, but Barriers to Access Remain
- Details
- Category: People Who Inject Drugs
- Published on Monday, 12 October 2015 00:00
- Written by Liz Highleyman
Hepatitis C treatment for people who inject drugs, including those receiving opioid substitution therapy (OST), was a major theme of the 4th International Symposium on Hepatitis Care in Substance Users (INHSU 2015) last week in Sydney. Studies show that treatment using new interferon-free regimens can be highly effective for this population, but barriers including high drug costs and stigma against drug users have hindered widespread access to therapy.
Coverage of 4th International Symposium on Hepatitis Care in Substance Users (INHSU 2015)
- Details
- Category: People Who Inject Drugs
- Published on Friday, 16 October 2015 00:00
- Written by HIVandHepatitis.com
Hepatitis C treatment for people who inject drugs, including those receiving opioid substitution therapy (OST), was a major theme of the 4th International Symposium on Hepatitis Care in Substance Users (INHSU 2015), October 7-9 in Sydney.
INHSU 2015 Highlights Hepatitis C Prevention and Treatment for People Who Inject Drugs
INHSU 2015: HCV Treatment Works Well for People Who Inject Drugs, but Barriers to Access Remain
10/16/15
INHSU 2015 Highlights Hepatitis C Prevention and Treatment for People Who Inject Drugs
- Details
- Category: People Who Inject Drugs
- Published on Wednesday, 07 October 2015 00:00
- Written by Liz Highleyman
An international group of researchers, healthcare providers, advocates, people who use drugs, and people living with hepatitis C are gathering this week in Sydney for the 4th International Symposium on Hepatitis Care in Substance Users, focusing on hepatitis C prevention, care, and treatment for injection drug users. The full program, with links to many of the presentations, is available online. Follow conference news on Twitter #INHSU2015.
More Articles...
- People Who Inject Drugs Should Have Access to Hepatitis C Treatment, Expert Panel Recommends
- People on Opiate Substitution Therapy Respond Well to AbbVie Hepatitis C Treatment
- AASLD 2014: Young Drug Injectors on Opioid Agonist Therapy Have Lower Risk of HCV Infection
- Opioid Maintenance Therapy Linked to Lower Hepatitis C Rates for People Who Inject Drugs
Web Design and Development by